Resultado de búsqueda
Hace 1 día · Though Lilly did just secure approval for another ulcerative colitis drug, analysts at Jefferies and the investment bank Stifel say they don't expect the Federal Trade Commission to take issue ...
Hace 1 día · July 8, 2024. Eli Lilly has agreed to acquire Morphic Therapeutic for $3.2 billion, in a deal designed to bolster the buyer’s pipeline with chronic disease candidates led by MORF-057, a Phase II ...
Hace 1 día · Lilly will commence a tender offer to acquire all outstanding shares of Morphic for a purchase price of $57 per share in cash or an aggregate of approximately $3.2 billion. Morphic is a ...
1 de jul. de 2024 · Truist Raises Price Target on Eli Lilly to $892 From $850, Keeps Buy Rating May. 01: MT Goldman Sachs Adjusts Price Target on Eli Lilly to $740 From $723 May. 01: MT Wells Fargo Adjusts Eli Lilly Price Target to $875 From $825
28 de jun. de 2024 · A list of analyst ratings for Eli Lilly (LLY) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts.
Hace 4 días · According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Eli Lilly and Company is $812.72, with a high forecast of $1,015.00 and a low forecast of $535.00. The consensus rating for Eli Lilly and Company stock is Moderate Buy based on the current 3 hold ratings and 16 buy ...
Hace 4 días · ELI LILLY AND COMPANY : Jefferies & Co. dégrade son opinion à neutre 07/06: ZM
